Skip to main content
. Author manuscript; available in PMC: 2016 Jul 25.
Published in final edited form as: Circulation. 2015 Nov 3;132(18 Suppl 2):S465–S482. doi: 10.1161/CIR.0000000000000262

2015 Guidelines Update: Part 8 Recommendations

Year Last
Reviewed
Topic Recommendation Comments
2015 Cardiovascular Care Coronary angiography should be performed emergently (rather than later in the hospital stay or not at all)
for OHCA patients with suspected cardiac etiology of arrest and ST elevation on ECG (Class I, LOE B-NR).
updated for 2015
2015 Cardiovascular Care Emergent coronary angiography is reasonable for select (e.g. electrically or hemodynamically unstable)
adult patients who are comatose after OHCA of suspected cardiac origin but without ST elevation on ECG
(Class IIa, LOE B-NR).
updated for 2015
2015 Cardiovascular Care Coronary angiography is reasonable in post–cardiac arrest patients for whom coronary angiography is
indicated regardless of whether the patient is comatose or awake (Class IIa, LOE C-LD).
updated for 2015
2015 Hemodynamic Goals Avoiding and immediately correcting hypotension (systolic blood pressure less than 90 mm Hg, MAP less
than 65 mm Hg) during postresuscitation care may be reasonable (Class IIb, LOE C-LD).
new for 2015
2015 Targeted Temperature
Management
We recommend that comatose (ie, lack of meaningful response to verbal commands) adult patients with
ROSC after cardiac arrest have TTM (Class I, LOE B-R for VF/pVT OHCA; Class I, LOE C-EO for non-VF/pVT
(ie, “nonshockable”) and in-hospital cardiac arrest).
updated for 2015
2015 Targeted Temperature
Management
We recommend selecting and maintaining a constant temperature between 32°C and 36°C during TTM
(Class I, LOE B-R).
updated for 2015
2015 Targeted Temperature
Management
It is reasonable that TTM be maintained for at least 24 hours after achieving target temperature (Class IIa,
LOE C-EO).
updated for 2015
2015 Targeted Temperature
Management
We recommend against the routine prehospital cooling of patients after ROSC with rapid infusion of cold
intravenous fluids (Class III: No Benefit, LOE A).
new for 2015
2015 Targeted Temperature
Management
It may be reasonable to actively prevent fever in comatose patients after TTM (Class IIb, LOE C-LD). new for 2015
2015 Other Neurologic Care An EEG for the diagnosis of seizure should be promptly performed and interpreted, and then should be
monitored frequently or continuously in comatose patients after ROSC (Class I, LOE C-LD).
updated for 2015
2015 Other Neurologic Care The same anticonvulsant regimens for the treatment of status epilepticus caused by other etiologies may
be considered after cardiac arrest (Class IIb, LOE C-LD).
updated for 2015
2015 Respiratory Care Maintaining the Paco2 within a normal physiological range, taking into account any temperature
correction, may be reasonable (Class IIb, LOE B-NR).
updated for 2015
2015 Respiratory Care To avoid hypoxia in adults with ROSC after cardiac arrest, it is reasonable to use the highest available
oxygen concentration until the arterial oxyhemoglobin saturation or the partial pressure of arterial oxygen
can be measured (Class IIa, LOE C-EO).
new for 2015
2015 Respiratory Care When resources are available to titrate the Fio2 and to monitor oxyhemoglobin saturation, it is reasonable
to decrease the Fio2 when oxyhemoglobin saturation is 100%, provided the oxyhemoglobin saturation can
be maintained at 94% or greater (Class IIa, LOE C-LD).
updated for 2015
2015 Other Critical Care
Interventions
The benefit of any specific target range of glucose management is uncertain in adults with ROSC after
cardiac arrest (Class IIb, LOE B-R).
updated for 2015
2015 Prognostication
of Outcome
The earliest time for prognostication using clinical examination in patients treated with TTM, where
sedation or paralysis could be a confounder, may be 72 hours after normothermia (Class IIb, LOE C-EO).
updated for 2015
2015 Other Critical Care
Interventions
We recommend the earliest time to prognosticate a poor neurologic outcome using clinical examination in
patients not treated with TTM is 72 hours after cardiac arrest (Class I, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
This time until prognostication can be even longer than 72 hours after cardiac arrest if the residual effect
of sedation or paralysis confounds the clinical examination (Class IIa, LOE C-LD).
new for 2015
2015 Other Critical Care
Interventions
In comatose patients who are not treated with TTM, the absence of pupillary reflex to light at 72 hours
or more after cardiac arrest is a reasonable exam finding with which to predict poor neurologic outcome
(FPR, 0%; 95% CI, 0%–8%; Class IIa, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
In comatose patients who are treated with TTM, the absence of pupillary reflex to light at 72 hours or
more after cardiac arrest is useful to predict poor neurologic outcome (FPR, 1%; 95% CI, 0%–3%; Class
I, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
We recommend that, given their unacceptable FPRs, the findings of either absent motor movements or
extensor posturing should not be used alone for predicting a poor neurologic outcome (FPR, 10%; 95% CI,
7%–15% to FPR, 15%; 95% CI, 5%–31%; Class III: Harm, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
The motor examination may be a reasonable means to identify the population who need further prognostic
testing to predict poor outcome (Class IIb, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
We recommend that the presence of myoclonus, which is distinct from status myoclonus, should not be
used to predict poor neurologic outcomes because of the high FPR (FPR, 5%; 95% CI, 3%–8% to FPR,
11%; 95% CI, 3%–26%; Class III: Harm, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
In combination with other diagnostic tests at 72 or more hours after cardiac arrest, the presence of status
myoclonus during the first 72 to 120 hours after cardiac arrest is a reasonable finding to help predict poor
neurologic outcomes (FPR, 0%; 95% CI, 0%–4%; Class IIa, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
In comatose post–cardiac arrest patients who are treated with TTM, it may be reasonable to consider
persistent absence of EEG reactivity to external stimuli at 72 hours after cardiac arrest, and persistent
burst suppression on EEG after rewarming, to predict a poor outcome (FPR, 0%; 95% CI, 0%–3%; Class
IIb, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
Intractable and persistent (more than 72 hours) status epilepticus in the absence of EEG reactivity to
external stimuli may be reasonable to predict poor outcome (Class IIb, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
In comatose post–cardiac arrest patients who are not treated with TTM, it may be reasonable to consider
the presence of burst suppression on EEG at 72 hours or more after cardiac arrest, in combination with
other predictors, to predict a poor neurologic outcome (FPR, 0%; 95% CI, 0%–11%; Class IIb, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
In patients who are comatose after resuscitation from cardiac arrest regardless of treatment with TTM, it
is reasonable to consider bilateral absence of the N20 SSEP wave 24 to 72 hours after cardiac arrest or
after rewarming a predictor of poor outcome (FPR, 1%; 95% CI, 0%–3%; Class IIa, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
In patients who are comatose after resuscitation from cardiac arrest and not treated with TTM, it may be
reasonable to use the presence of a marked reduction of the GWR on brain CT obtained within 2 hours
after cardiac arrest to predict poor outcome (Class IIb, LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
It may be reasonable to consider extensive restriction of diffusion on brain MRI at 2 to 6 days after cardiac
arrest in combination with other established predictors to predict a poor neurologic outcome (Class IIb,
LOE B-NR).
new for 2015
2015 Other Critical Care
Interventions
Given the possibility of high FPRs, blood levels of NSE and S-100B should not be used alone to predict a
poor neurologic outcome (Class III: Harm, LOE C-LD).
updated for 2015
2015 Other Critical Care
Interventions
When performed with other prognostic tests at 72 hours or more after cardiac arrest, it may be
reasonable to consider high serum values of NSE at 48 to 72 hours after cardiac arrest to support the
prognosis of a poor neurologic outcome (Class IIb, LOE B-NR), especially if repeated sampling reveals
persistently high values (Class IIb, LOE C-LD).
updated for 2015
2015 Other Critical Care
Interventions
We recommend that all patients who are resuscitated from cardiac arrest but who subsequently progress
to death or brain death be evaluated for organ donation (Class I, LOE B-NR).
updated for 2015
2015 Other Critical Care
Interventions
Patients who do not have ROSC after resuscitation efforts and who would otherwise have termination of
efforts may be considered candidates for kidney or liver donation in settings where programs exist (Class
IIb, LOE B-NR).
new for 2015
The following recommendations were not reviewed in 2015. For more information, see the 2010 AHA Guidelines for CPR and ECC, “Part 9: Post–Cardiac Arrest Care.”
2010 Systems of Care for
Improving Post–Cardiac
Arrest Outcomes
A comprehensive, structured, multidisciplinary system of care should be implemented in a consistent
manner for the treatment of post–cardiac arrest patients (Class I, LOE B).
not reviewed in 2015
2010 Treatment of
Pulmonary Embolism
After CPR
In post–cardiac arrest patients with arrest due to presumed or known pulmonary embolism, fibrinolytics
may be considered (Class IIb, LOE C).
not reviewed in 2015
2010 Sedation After
Cardiac Arrest
It is reasonable to consider the titrated use of sedation and analgesia in critically ill patients who require
mechanical ventilation or shivering suppression during induced hypothermia after cardiac arrest (Class
IIb, LOE C).
not reviewed in 2015
2010 Cardiovascular
System
A 12-lead ECG should be obtained as soon as possible after ROSC to determine whether acute ST
elevation is present (Class I, LOE B).
not reviewed in 2015
2010 Neuroprotective The routine use of coenzyme Q10 in patients treated with hypothermia is uncertain (Class IIb, LOE B). not reviewed in 2015
2010 Evoked Potentials Bilateral absence of the N20 cortical response to median nerve stimulation after 24 hours predicts poor
outcome in comatose cardiac arrest survivors not treated with therapeutic hypothermia (Class IIa, LOE A).
not reviewed in 2015